S&P 500
5,921.54
+2.0%
+$118.72
DJI
42,343.65
+1.8%
+$740.58
NASDAQ
19,199.16
+2.5%
+$461.96
Bitcoin
109,872.00
+0.6%
+662.98
AAPL
$200.00
+2.4%
+$4.73
AMZN
$205.78
+2.4%
+$4.79
GOOG
$173.90
+2.5%
+$4.32
META
$641.62
+2.3%
+$14.56
MSFT
$460.09
+2.2%
+$9.91
NVDA
$135.32
+3.1%
+$4.03
TSLA
$361.87
+6.6%
+$22.53
Hard To Treat Diseases (OTC: HTDS)
$0.00
Hard To Treat Diseases Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Hard To Treat Diseases Company Info
Hard to Treat Diseases, Inc. engages in the research, development, purchase, sale and marketing of biological vaccine. Its subsidiaries include Shenzhen Mellow Hope Pharm Industrial Co. Ltd. and Slavica BioChem. The company was founded in 1993 and is headquartered in Clearwater, FL.
News & Analysis
No articles found.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.